Sargent Bickham Lagudis LLC: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Sargent Bickham Lagudis LLC on CVS, newest first. How the timeline and the estimate are built.

Sargent Bickham Lagudis LLC held 9,449 CVS shares at 2022-12-31 per its 13F-HR filed 2023-01-23.

the latest 13F is the newest step

period ended2022-12-31
13F 9,449 shares
Change vs previous 13F +29 shares
0.07% of the 13F portfolio, value $880,513.
13F-HR 0001613939-23-000001 filed by Sargent Bickham Lagudis LLC
Filed 2023-01-23 (acceptance time not in the bulk data set), ingested 2026-10-07 18:33:21 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2022-09-30
13F 9,420 shares
Change vs previous 13F -115 shares
0.08% of the 13F portfolio, value $899,000.
13F-HR 0001613939-22-000006 filed by Sargent Bickham Lagudis LLC
Filed 2022-10-27 (acceptance time not in the bulk data set), ingested 2026-10-07 18:34:10 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2022-06-30
13F 9,535 shares
Change vs previous 13F +398 shares
0.08% of the 13F portfolio, value $883,000.
13F-HR 0001613939-22-000005 filed by Sargent Bickham Lagudis LLC
Filed 2022-07-13 (acceptance time not in the bulk data set), ingested 2026-10-07 18:35:03 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2022-03-31
13F 9,137 shares
Change vs previous 13F not available
0.07% of the 13F portfolio, value $925,000.
13F-HR 0001613939-22-000004 filed by Sargent Bickham Lagudis LLC
Filed 2022-04-27 (acceptance time not in the bulk data set), ingested 2026-10-07 18:35:57 UTC
Acceptance time not in the bulk data set (spec §4.2).